Multiple Myeloma

Feasibility of a Digital Life Coaching Intervention for Patients Undergoing SCT for Multiple Myeloma

By

Jessica Nye, PhD

Publish Date January 25, 2022

Researchers investigated whether digital life coaching could help patients manage their anxiety, emotional distress, and sleep disturbances.

5-Gene Risk Score Model Effectively Predicts Prognosis in Multiple Myeloma

By

Jennifer Larson

Publish Date January 10, 2022

Researchers sought to develop and validate a risk score model to predict prognosis for patients with multiple myeloma.

Patient Perspective on Their Prognosis Affects QOL, Psychological Distress in MM

By

John Schieszer

Publish Date December 17, 2021

This study investigated the effects of patients’ perceptions of their disease status and prognosis on quality of life and psychological distress.

Model Serves as Tool to Identify Subgroups of Newly Diagnosed Multiple Myeloma

By

Vicki Moore, PhD

Publish Date December 3, 2021

A new model identifies subgroups of patients with newly diagnosed multiple myeloma based on genomic and transcriptional data and patient outcomes.

Treatment Duration and Interval of Bortezomib, Lenalidomide for MM Predictive of Skin Rash

By

Jessica Nye, PhD

Publish Date November 25, 2021

A retrospective review sought to better understand the relationship between bortezomib and lenalidomide therapy and treatment-induced skin rash in multiple myeloma.